Jeffrey H. Knapp
Overview
Jeffrey H. Knapp received an average of $3M in total compensation, including $370K in salary, at Aimmune Therapeutics between 2016 and 2017.
Source: SEC filing on April 11, 2018.
Related executives
We found nine more executives who work or worked at Aimmune Therapeutics.
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
Susan Barrowcliffe
Aimmune Therapeutics
General Manager, Europe
Warren DeSouza
Aimmune Therapeutics